J&J(US:JNJ) ZACKS·2025-11-26 15:51Core Insights - Zacks Premium offers various tools for investors to enhance their stock market engagement and confidence [1] - The Zacks Style Scores provide a framework for evaluating stocks based on value, growth, and momentum characteristics [2][3][4][5][6] Zacks Style Scores Overview - Stocks are rated from A to F based on their potential to outperform the market, with A being the highest score [3] - The Style Scores are categorized into Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] Value Score - The Value Score identifies attractive stocks using financial ratios like P/E, PEG, and Price/Sales, appealing to value investors [3] Growth Score - The Growth Score emphasizes a company's financial health and future outlook, analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Score focuses on price trends and earnings outlook changes, helping investors capitalize on upward or downward price movements [5] VGM Score - The VGM Score combines the three Style Scores to identify stocks with the best value, growth potential, and momentum [6] Zacks Rank Integration - The Zacks Rank utilizes earnings estimate revisions to guide stock selection, with 1 (Strong Buy) stocks historically yielding an average annual return of +23.93% since 1988 [7][8] - Investors are encouraged to focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal returns [10] Johnson & Johnson (JNJ) Analysis - Johnson & Johnson is recognized for its diversified business model, operating in pharmaceuticals and medical devices with over 275 subsidiaries [12] - JNJ holds a Zacks Rank of 3 (Hold) and a VGM Score of B, with a Momentum Style Score of B, reflecting a 10.6% increase in shares over the past four weeks [13] - Recent upward revisions in earnings estimates for fiscal 2025 indicate positive momentum, with the Zacks Consensus Estimate rising to $10.87 per share [13][14]